Keywords: opexa, ms, drug, fails, meet, endpoints, texas

Opexa MS drug fails to meet endpoints

Article | 29 September 2008

Texas, USA-based Opexa Therapeutics, a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing